HomeYMAB • NASDAQ
add
Y-mAbs Therapeutics Inc
Previous close
$15.55
Day range
$12.47 - $15.68
Year range
$4.69 - $20.90
Market cap
689.94M USD
Avg Volume
183.55K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Revenue | 22.80M | 9.86% |
Operating expense | 29.57M | 26.79% |
Net income | -9.25M | -46.76% |
Net profit margin | -40.57 | -33.59% |
Earnings per share | -0.21 | -50.00% |
EBITDA | -9.64M | -37.68% |
Effective tax rate | -1.09% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 77.81M | -11.49% |
Total assets | 144.04M | 8.79% |
Total liabilities | 48.70M | 75.71% |
Total equity | 95.34M | — |
Shares outstanding | 44.57M | — |
Price to book | 7.27 | — |
Return on assets | -18.31% | — |
Return on capital | -24.85% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Net income | -9.25M | -46.76% |
Cash from operations | 298.00K | 106.29% |
Cash from investing | — | — |
Cash from financing | 1.76M | — |
Net change in cash | 2.06M | 143.58% |
Free cash flow | 6.95M | 495.38% |
About
Founded
2015
Website
Employees
100
